Engineered graphene quantum dot nanocomposite triggers α-synuclein defibrillation: Therapeutics against Parkinson's disease

Ozansoy, 2013, The central theme of Parkinson's disease: α-synuclein, Mol Neurobiol, 47, 460, 10.1007/s12035-012-8369-3 Jankovic, 2020, Parkinson's disease: etiopathogenesis and treatment, J Neurol Neurosurg Psychiatry, 91, 795, 10.1136/jnnp-2019-322338 Sinha, 2014, Roche bets on alpha-synuclein for Parkinson's, Nat Biotechnol, 32, 212, 10.1038/nbt0314-212a Uversky, 2009, Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein, Curr Protein Pept Sci, 10, 483, 10.2174/138920309789351921 Mao, 2016, Functional nanoparticles for magnetic resonance imaging, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 8, 814, 10.1002/wnan.1400 Melino, 2011, Allyl sulfur compounds and cellular detoxification system: effects and perspectives in cancer therapy, J Amino Acids, 41, 103, 10.1007/s00726-010-0522-6 Yoshioka, 2021, Inhibitory activities of sulfur compounds in garlic essential oil against Alzheimer's disease-related enzymes and their distribution in the mouse brain, J Agric Food Chem, 69, 10163, 10.1021/acs.jafc.1c04123 Miciek, 2012, Effects of different garlic-derived allyl sulfides on peroxidative processes and anaerobic sulfur metabolism in mouse liver, Phytother Res, 26, 425, 10.1002/ptr.3572 Ogawa, 2016, Natural thioallyl compounds increase oxidative stress resistance and lifespan in Caenorhabditis elegans by modulating SKN-1/Nrf, Sci Rep, 6, 21611, 10.1038/srep21611 Shilo, 2015, The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model, J Nanobiotechnol, 13, 19, 10.1186/s12951-015-0075-7 Wu, 2019, Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide, Nat Commun, 10, 4635, 10.1038/s41467-019-12554-2 Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat Biotechnol, 33, 941, 10.1038/nbt.3330 Some, 2014, Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives, Sci Rep, 10, 6314, 10.1038/srep06314 Kim, 2018, Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease, Nat Nanotechnol, 13, 812, 10.1038/s41565-018-0179-y Siddique, 2020, Application of nanomaterials in biomedical imaging and cancer therapy, Nanomaterials, 10, 1700, 10.3390/nano10091700 Predmore, 2012, Hydrogen sulfide in biochemistry and medicine, Antioxid Redox Signal, 17, 119, 10.1089/ars.2012.4612 Zhu, 2021, Sulfur-containing therapeutics in the treatment of Alzheimer's disease, Med Chem Res, 30, 305, 10.1007/s00044-020-02687-1 Chun, 2008, Neuroprotective effects of several Korean medicinal plants traditionally used for stroke remedy, J Med Food, 11, 246, 10.1089/jmf.2007.542 Zhang, 2020, Phytochemicals of garlic: promising candidates for cancer therapy, Biomed Pharmacother, 123, 10.1016/j.biopha.2019.109730 De, 2020, Curcumin complexed with graphene derivative for breast cancer therapy, ACS Appl Bio Mater, 3, 6284, 10.1021/acsabm.0c00771 Javanbakht, 2018, Doxorubicin loaded carboxymethyl cellulose/graphene quantum dot nanocomposite hydrogel films as a potential anticancer drug delivery system, Korean J Couns Psychother, 87, 50 Maio, 2021, An overview of functionalized graphene nanomaterials for advanced applications, Nanomaterials, 11, 1717, 10.3390/nano11071717 Tachi, 2019, Quantum yield enhancement in graphene quantum dots via esterification with benzyl alcohol, Sci Rep, 9, 14115, 10.1038/s41598-019-50666-3 Behiye, 2019, Graphene quantum dots: synthesis, characterization, cell viability, genotoxicity for biomedical applications, Saudi Pharm J, 27, 846, 10.1016/j.jsps.2019.05.006 Jana, 2015, Structural and electrochemical analysis of a novel co-electrodeposited Mn2O3-au nanocomposite thin film, Dalton Trans, 44, 9158, 10.1039/C5DT01025J Yan, 2019, Recent advances on graphene quantum dots: from chemistry and physics to applications, Adv Mater, 31, 10.1002/adma.201808283 Li, 2019, Early stages of aggregation of engineered alpha-synuclein monomers and oligomers in solution, Sci Rep, 9, 1734, 10.1038/s41598-018-37584-6 Fields, 2019, Targeting alpha-synuclein as a therapy for Parkinson's disease, Front Mol Neurosci, 12, 299, 10.3389/fnmol.2019.00299 Vittorio, 2020, Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease, J Enzyme Inhib Med Chem, 35, 1727, 10.1080/14756366.2020.1816999 Save, 2019, Natural compound safranal driven inhibition and dis-aggregation of α-synuclein fibrils, Int J Biol Macromol, 141, 585, 10.1016/j.ijbiomac.2019.09.053 Fazili, 2015, Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human α-synuclein: implications for Parkinson's disease, Biochimie, 108, 178, 10.1016/j.biochi.2014.11.011 Flynn, 2018, Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy, J Biol Chem, 293, 767, 10.1074/jbc.M117.812388 Aliakbari, 2018, The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's disease, Nanoscale, 10, 9174, 10.1039/C8NR00632F Chen, 2020, Lactulose and melibiose inhibit α-synuclein aggregation and up-regulate autophagy to reduce neuronal vulnerability, Cells, 9, 1230, 10.3390/cells9051230 Wu, 2018, Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synuclein, Neural Regen Res, 13, 1375, 10.4103/1673-5374.235250 Guo, 2019, Age- and brain region-associated alterations of cerebral blood flow in early Alzheimer's disease assessed in AβPPSWE/PS1ΔE9 transgenic mice using arterial spin labelling, Mol Med Rep, 19, 3045 Ma, 2008, In vivo 3D digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy, Front Neuroanat, 2, 1, 10.3389/neuro.05.001.2008 Wang, 2019, Catalpol exerts a neuroprotective effect in the MPTP mouse model of Parkinson's disease, Front Aging Neurosci, 11, 316, 10.3389/fnagi.2019.00316